What is the appropriate management for eczematous contact dermatitis?

Management of Eczematous Contact Dermatitis

The cornerstone of managing eczematous contact dermatitis is identifying and avoiding the causative agent through patch testing, combined with topical corticosteroids for acute inflammation and emollients for barrier repair. 1

Diagnostic Approach

History Taking

Take a detailed history focusing on 1:

• Onset location and spread pattern - where symptoms began and how they progressed
• Product exposure - cosmetics, personal care products, topical medications, clothing, bandages, gloves
• Occupational factors - work activities, products handled, improvement during weekends/holidays
• Wash products - all soaps and cleansers (most contain harsh surfactants damaging the skin barrier)
• Atopic history - personal/family history of atopic dermatitis, asthma, hay fever
• Sunlight relationship - worsening with sun exposure suggests photoallergic component

Clinical Assessment

Use standardized tools for both initial assessment and treatment monitoring 1:

• Dermatology Life Quality Index (DLQI) - for quality of life impact
• Hand Eczema Severity Index (HECSI) - for objective severity scoring in hand dermatitis

Patch Testing - The Gold Standard

Offer patch testing to all patients with chronic or persistent dermatitis 1. Clinical features alone are unreliable in distinguishing allergic contact dermatitis from irritant or endogenous dermatitis, particularly for hand and facial involvement.

Key patch testing recommendations:

• Test with baseline allergen series at minimum 1
• Add exposure-specific series based on occupational/recreational exposures 1
• Consider additional readings at day 6-7 if day 4 results are unexpectedly negative 1
• Defer testing 3 months after systemic immunosuppressants and 6 months after biologics to minimize false-negatives 1

Treatment Algorithm

First-Line: Topical Therapy

Topical corticosteroids remain the primary treatment for acute inflammation 2, 3:

• Localized disease: Mid- to high-potency topical steroids (triamcinolone 0.1% or clobetasol 0.05%) 3
• Extensive involvement (>20% body surface area): Consider systemic steroids initially, then transition to topical therapy 3

Critical caveat: TCS should be limited to intermittent short-term use due to side effects 4. Do not use continuously for chronic management.

Topical tacrolimus - Consider when topical steroids are unsuitable or ineffective 1. This is a weak recommendation but provides a steroid-sparing option for maintenance therapy.

Supportive Measures (Essential for All Patients)

Emollients and soap substitutes 2:

• Use liberally and frequently for barrier repair
• Controlled trials demonstrate benefit in reducing incidence and prevalence (Quality of evidence I)
• Should be readily available, especially in occupational settings

Allergen/irritant avoidance 1:

• Once identified through patch testing, provide clear written instructions
• For occupational exposures, review workplace practices and safety data sheets
• Follow-up visits to reinforce and clarify avoidance strategies

Second-Line Therapies for Severe/Refractory Disease

When first-line treatments fail, consider 1, 2:

For severe chronic hand eczema specifically:

• Alitretinoin - Strong recommendation; offer to patients with severe chronic hand eczema 1
• PUVA therapy - Consider for chronic hand eczema 1

For steroid-resistant chronic dermatitis:

• Azathioprine, ciclosporin, or methotrexate 2
• Supported by prospective clinical trials (Quality of evidence I)

Special Considerations

Occupational Contact Dermatitis

• Patient education is essential 1
• Implement skin care and skin protection creams for prevention 1
• After-work creams confer protection against irritant contact dermatitis 2
• Document work-relatedness: improvement away from work, recurrence on return

Severe Rhus (Poison Ivy) Dermatitis

Taper oral prednisone over 2-3 weeks 3. Rapid discontinuation causes rebound dermatitis - a common pitfall leading to treatment failure.

Infected Eczema

Consider combined topical corticosteroid/antibiotic for infected or potentially infected eczema, though evidence shows only marginal benefit 2. However, be aware that topical antibiotics themselves are important causes of allergic contact dermatitis 5.

Common Pitfalls to Avoid

1. Assuming clinical appearance distinguishes allergic from irritant dermatitis - it doesn't, especially on hands and face 1
2. Not patch testing chronic/persistent cases - allergic contact dermatitis carries worse prognosis than irritant dermatitis unless allergen identified and avoided 1, 2
3. Patch testing while on immunosuppressants - wait appropriate intervals to avoid false-negatives 1
4. Rapid steroid taper in extensive disease - causes rebound 3
5. Overlooking occupational factors - detailed work history is mandatory 1
6. Continuous long-term TCS use - increases side effect risk; transition to steroid-sparing maintenance 4

Prognosis Considerations

Allergic contact dermatitis generally carries a worse prognosis than irritant contact dermatitis unless the allergen is identified and avoided 1, 2. This underscores why patch testing is not optional for persistent cases - it directly impacts long-term morbidity and quality of life.